CASI Pharmaceuticals Financial Overview
CASI Pharmaceuticals's market cap is currently $13.05M. The company's EPS TTM is $-0.68; its P/E ratio is -0.26; CASI Pharmaceuticals is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
